On September 21, the 2Firsts team discovered that some brand manufacturers had taken advantage of the popularity of nicotine pouches at the tobacco expo in Dortmund, Germany, by introducing a similar product called nicotine oral film.
Avoid the market for nicotine pouches.
At the NUSO company booth, it was discovered that they were showcasing their Orgco brand nicotine oral films. According to booth staff, the product is designed to differentiate itself from the competitive nicotine pouch market.
According to the booth staff, faced with the oversaturated nicotine pouch market, the company has decided not to compete directly, but instead to introduce this more discreet and convenient alternative nicotine product.
According to reports, the nicotine oral film of the orgco brand is produced in the company's factory in Indonesia, with a nicotine content of 2% in the product. Although it has not yet undergone large-scale marketing, the volume of inquiries during the exhibition period has been "quite substantial." One audience member who experienced it on-site commented that the nicotine oral film, compared to other nicotine replacement products on the market, still needs time to be tested by the market.
Currently, the brand's products have not yet been officially launched on the market.
In addition, the two leaders also noticed several other nicotine oral film products. China Boton Group showcased a nicotine oral film called "ECHI" at their booth, these products were displayed alongside the brand's nicotine pouches on the display table.
Another brand called "melta" offers a variety of flavored nicotine oral films to choose from. The brand's representatives stated that their products are already on the market and selling well in Europe and the United States.
The product's mechanism of action is similar to that of a nicotine pouch.
The core technology of nicotine oral film lies in its fast-dissolving design. Two recent patent searches have revealed that "nicotine dissolvable film with or without mint flavor" is a type of rapidly dissolving film placed in the mouth, containing "nicotine or nicotine analogs, with or without mint flavor or mint flavor analogs". It can be directly absorbed into the bloodstream through the oral mucosa, with the purpose of satisfying temporary nicotine cravings when unable to smoke, or for therapeutic purposes.
Nicotine pouches are also absorbed through the oral mucosa, and they share similarities with traditional snus in terms of usage. However, nicotine pouches require saliva in order for the nicotine to be released more effectively, which is then absorbed through the oral mucosa.
Compared to nicotine pouches and other oral tobacco products, the advantage of nicotine oral film is that the product does not need to be spit out after use.
Like with a nicotine pouch, you may need to eventually spit out the packaging, but with this nicotine oral film, it simply dissolves and doesn't need to be spit out, that's the advantage," explained a representative of the brand.
According to a study, although nicotine oral films have been introduced in the European and American markets, concerns about side effects and efficacy still exist in the market, especially when users experience common discomforts such as palpitations and throat irritation.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
